RegulatoryRegulatoryPHN-03052026-10-20 10:57 CT
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
Source · FDA press releases
TLDR
The FDA approved the first generic version of Climara Pro, an estradiol and levonorgestrel transdermal hormone therapy patch. The approval covers a patch for women with an intact uterus.
01—Key points
- 01The FDA announcement identifies this as the first generic of Climara Pro.
- 02The patch contains estradiol and levonorgestrel.
- 03No peptides from the provided list are mentioned.
Why it matters Editorial
The approval introduces a generic version of an existing hormone therapy patch, but the announcement has little relevance to peptides.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.